Curaleaf Announces Receipt of Conditional Approval to List Subordinate Voting Shares on the TSX

NEW YORK, Dec. 7, 2023 – PRESS RELEASE – Curaleaf Holdings Inc., a leading international provider of consumer products in cannabis, announced that it has received conditional approval from the Toronto Stock Exchange (TSX) to list its subordinate voting shares on the TSX.

"We are excited to announce that Curaleaf has received conditional approval to join the Toronto Stock Exchange," Curaleaf Executive Chairman Boris Jordan said. "We are now one step closer to accessing an even broader set of global institutional investors than we currently have, alongside the capital and increased liquidity that comes with listing on a major exchange such as the TSX."

Final approval of the TSX listing is subject to the company meeting certain customary conditions required by the TSX. Curaleaf will issue a press release once such TSX listing conditions are satisfied and the TSX confirms the date that trading of the subordinate voting shares will commence on the TSX.

In connection with the TSX listing, the company intends to submit a request to voluntarily delist its shares from the Canadian Securities Exchange (CSE). The CSE delisting is expected to be effective on or shortly after the date the shares commence trading on the TSX.